Cargando…

Automated assessment of steatosis in murine fatty liver

Although mice are commonly used to study different aspects of fatty liver disease, currently there are no validated fully automated methods to assess steatosis in mice. Accurate detection of macro- and microsteatosis in murine models of fatty liver disease is important in studying disease pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sethunath, Deepak, Morusu, Siripriya, Tuceryan, Mihran, Cummings, Oscar W., Zhang, Hao, Yin, Xiao-Ming, Vanderbeck, Scott, Chalasani, Naga, Gawrieh, Samer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945052/ https://www.ncbi.nlm.nih.gov/pubmed/29746543 http://dx.doi.org/10.1371/journal.pone.0197242

Ejemplares similares

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

The Liver in Systemic Illness
por: Chalasani, Naga, et al.
Publicado: (2006)

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial
por: Gawrieh, Samer, et al.
Publicado: (2021)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016)

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study
por: Corey, Kathleen E, et al.
Publicado: (2017)

Integrative omics analysis identifies macrophage migration inhibitory factor signaling pathways underlying human hepatic fibrogenesis and fibrosis
por: Liu, Zhipeng, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting
por: Culver, Alexander, et al.
Publicado: (2023)

Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding
por: Liang, Tiebing, et al.
Publicado: (2023)

Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study
por: deLemos, Andrew, et al.
Publicado: (2020)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease
por: Westerkamp, Andrie C., et al.
Publicado: (2015)

Augmented Reality-Assisted Deep Reinforcement Learning-Based Model towards Industrial Training and Maintenance for NanoDrop Spectrophotometer
por: Alatawi, Hibah, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus
por: Gawrieh, Samer, et al.
Publicado: (2023)

Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
por: Mathur, Karan, et al.
Publicado: (2021)

Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials
por: Athinarayanan, Shaminie, et al.
Publicado: (2014)

Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
por: Marinho, Polyana C., et al.
Publicado: (2018)

A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH
por: Gawrieh, Samer, et al.
Publicado: (2019)

Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation
por: Hammad, Seddik, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation
por: Shama, Samaa, et al.
Publicado: (2023)

Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
por: Patidar, Kavish R., et al.
Publicado: (2021)

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
por: Ferro, Yvelise, et al.
Publicado: (2022)

Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis
por: Niture, Suryakant, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
por: Pirozzi, Anna Virginia Adriana, et al.
Publicado: (2020)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
por: Chalasani, Naga, et al.
Publicado: (2023)

Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
por: Rao, Prahlad K., et al.
Publicado: (2018)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
por: SAWANO, TAKEYUKI, et al.
Publicado: (2015)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis
por: Hua, Man-Chin, et al.
Publicado: (2017)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence
por: Melton, Phillip E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljicoo2ll82ggnhg5p10keu4ru